Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04660760
Title Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma


Paclitaxel + Ramucirumab

Ramucirumab + Trifluridine-tipiracil hydrochloride

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.